Escolar Documentos
Profissional Documentos
Cultura Documentos
Aberrao Esfrica Zero Reduo de Aberrao Cromtica No associado a Glistenings Luz Azul saudvel Borda protetora 360
Sinergia ptica
Menos migrao de clulas epiteliais do cristalino Menos incidncia de Glistenings Transmisso de luz azul saudvel Menos Aberrao Cromtica Aberrao Esfrica Zero
Qualidade de Viso
ViSo gerAl
Aberrao Esfrica residual em lentes monofocais14 Medida LIO TECNIS LIO AcrySof LIO SofPort AO LIO Esfrica
20/20*
Mdia Aberrao Esfrica da Crnea Aberrao Esfrica da LIO Aberrao Esfrica Residual
* Imagens simuladas atravs do Zernike Tool, com 6 mm de abertura, criada por George Dai, PhD. Correo da Aberrao Esfrica em crnea plana.
www.liotecnis.com.br
sfrica Zero
Desempenho visual otimizado em condies de pouca luz
FTM* (50c/mm) de LIOs em modelo de tamanho mdio de crnea (pupila de 5mm)2
Sinergia ptica
AberrAo eSFricA
Correo total de aberraes importante especialmente em condies de pouca luz. TECNIS 1 Pea nica proporciona melhor eficincia de FTM em condies de pouca luz, o que pode ser significativo para seus pacientes.1,2
TECNIS AcrySof IQ HOYA-PS ZCB00 SN60WF AF-1 SofPort LI61A0
LIO AcrySof IQ
LIO Hoya-PS
LIO SofPort
* Frequncia de Transferncia de Modulao (FTM) a medida da transferncia de contraste de um objeto para uma imagem. Em outras palavras, mede a qualidade da imagem transmitida pela LIO.
60 50 40
55 47 43 37
30 20 10 0
www.liotecnis.com.br
berrao cromtica
resultados visuais superiores atravs da combinao da correo da aberrao cromtica e aberrao esfrica
Melhora na FTM13
Sinergia ptica
AberrAo cromTicA
30
29
20
%
A correo de aberrao cromtica e aberrao esfrica em conjunto mais benfico do que as duas correes individuais.13,22,23 Um estudo recente comparando a reduo de aberrao esfrica e cromtica da TECNIS 1 Pea nica e AcrySof mostrou que a TECNIS 1 Pea nica proporciona significativos 29% de melhora na performance da FTM.13
10
12
13
0
Correo da aberrao Correo da aberrao Correo da aberrao cromtica esfrica cromtica e esfrica
Tecnis 1 Pea nica pode proporcionar at 21% mais sensibilidade escotpica comparada com uma LIO que bloqueia a luz azul.4
0
-15 -21
-14
Verde Amarelo Laranja Vermelho UV Violeta Azul <400 400-440 440-500 500-570 570-590 590-610 610-700
350
400
450
500
550
600
650
700
www.liotecnis.com.br
Sinergia ptica
Tecnis 1 Pea nica pode proporcionar at 38% mais supresso de melatonina comparada com uma LIO que bloqueia a luz azul.4
0 -5 -10 -15 -20 -25 -30 -35 -40
luZ AZul
0.8
-27
-27
-38
AcrySof Natural 30D Hoya 20D IOL AcrySof Natural 20D TECNIS 1 Pea nica
Verde Amarelo Laranja Vermelho UV Violeta Azul <400 400-440 440-500 500-570 570-590 590-610 610-700
350
400
450
500
550
600
650
700
www.liotecnis.com.br
Sinergia ptica
33.5 26.9
20 15 10 5 0
Suave Mild Moderada a Moderate toSevera Severe
gliSTeningS
Migrao de clulas epiteliais frequentemente vista na juno da ala com o corpo ptico da lente AcrySof.7
A borda ProTEC 360 proporciona contato ininterrupto na juno, minimizando a migrao de clulas epiteliais.7
www.liotecnis.com.br
Sinergia ptica
O desenho da lente proporciona uma fixao em 3 pontos no saco capsular, resultando maior estabilidade e mais centrao. O reforado contato entre a poro posterior da lente com a poro anterior da cpsula posterior foi desenvolvido para:
3 pontos de fixao
Limitar a migrao de clulas com a borda de proteo ProTEC. Fazer com que as clulas epiteliais fiquem no canto externo da borda, mas fora da zona ptica, o que refora a centrao e a estabilidade da lente.
Lado posterior
Lado posterior
migrAo De clulAS
Sinergia ptica com TecniS 1 resultados visuais superiores atravs de uma combinao patenteada das tecnologias de ptica, material e design trabalhando em conjunto.
referncias
1. TECNIS Foldable Posterior Chamber Intraocular Lens [package insert]. Santa Ana, Calif; Abbott Medical Optics Inc. 2. Terwee T, van der Mooren M, Piers P. Optical performance of TECNIS LIOs compared with LIOs that partly compensate for the mean SA of the human cornea. Presented at: Annual Meeting of the American Society of Cataract and Refractive Surgery; 2008 Apr 49; Chicago. 3. Zhao H, Mainster MA. The effect of chromatic dispersion on pseudophakic optical performance. Br J Ophthalmol. 2007;91(9):1225-1229. 4. Mainster MA. VLIOet and blue-light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol. 2006;90:784-792. 5. Gunenc U, Oner FH, Tongal S, Ferliel M. Effects on visual function of glistenings and folding marks in AcrySof intraocular lenses. J Cataract Refract Surg. 2001;27:1611-4. 6. Christiansen G, Durcan FJ, Olson RJ, Christiansen K. Glistenings in the AcrySof intraocular lens: pilot study. J Cataract Refract Surg. 2001;27:728-33. 7. Nixon DR. New technologies for premium outcomes: next generation phaco and TECNIS 1-Piece LIO. Presented at 25th Congress of ESCRS; 2007 Sep 812; Stockholm, Sweden. 8. Artal P, Alcn E, Villegas E. Spherical aberration in young subjects with high visual acuity. Paper 558. Presented at: 24th Congress of the ESCRS; 2006 Sep 913; London, England. 9. Smith G, Cox MJ, Calver R, Garner LF. The spherical aberration of the crystalline lens of the human eye. Vision Res. 2001;41:235-243. 10. Glasser A, Campbell MC. Presbyopia and the optical changes in the human crystalline lens with age. Vision Res. 1998;38:209-29. 11. Guirao A, Gonzalez C, Redondo M, et al. Average optical performance of the human eye as a function of age in a normal population. Invest Ophthalmol Vis Sci. 1999;40(1):203-13. 12. Wang L, Koch D. Ocular higher-order aberrations in individuals screened for refractive surgery. J Cataract Refract Surg. 2003;29(10);1896-1903. 13. Zhao H, Piers PA, Mainster MA. The additive effects of different optical design elements contributing to contrast loss in pseudophakic eyes implanted with different aspheric LIOs. Presented at: 27th Congress of the ESCRS; 2009 Sep 48; Barcelona, Spain. 14. Data on file. Santa Ana, Calif; Abbott Medical Optics Inc. 15. Holladay JT, Piers PA, Koranyi G, et al. A new intraocular lens design to reduce spherical aberration of pseudophakic eyes. J Refract Surg. 2002;18:683-691. 16. Mester U, Dillinger P, Anterist N. Impact of a modified optic design on visual function: clinical comparative study. J Cataract Refract Surg. 2003;29:652-660. 17. Bellucci R, Morselli S, Piers P. Comparison of wavefront aberrations and optical quality of eyes implanted with five different intraocular lenses. J Refract Surg. 2004;20:297-306. 18. Kennis H, Huygens M, Callebaut F. Comparing the contrast sensitivity of a modified prolate anterior surface LIO and of two spherical LIOs. Bull Soc Belge Ophtalmol. 2004;294:49-58. 19. Packer M, Fine IH, Hoffman RS, Piers PA. Prospective randomized trial of an anterior surface modified prolate intraocular lens. J Refract Surg. 2002;18(6):692-696. 20. Kershner RM. Retinal image contrast and functional visual performance with aspheric, silicone, and acrylic intraocular lenses. Prospective evaluation. J Cataract Refract Surg. 2003;29(9):1684-1694. 21. Negishi K, Ohnuma K, Hirayama N, Noda T. Effect of chromatic aberration on contrast sensitivity in pseudophakic eyes. Arch Ophthalmol. 2001;119:1154-1158. 22. Yoon GY, Williams DR. Visual performance after correcting the monochromatic and chromatic aberrations of the eye. J Opt Soc Am A Opt Image Sci Vis. 2002;19:266-75. 23. Manzanera S, Piers P, Weeber H, Artal P. Visual benefit of the combined correction of spherical and chromatic aberrations. Invest Ophthalmol Vis Sci. 2007;48:E-Abstract 1513. 24. Chew EY, Sperduto RD, Milton RC, et al. Risk of advanced age-related macular degeneration after cataract surgery: AREDS report 25. Ophthalmology. 2009;116:297-303. 25. Owsley C, McGwin G Jr, Scilley K, Kallies K. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. Invest Ophthalmol Vis Sci. 2006;47(2):528-535. 26. Scilley K, Jackson G, Cideciyan A, et al. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002;109(7):1235-42. 27. Zaidl FH, Hull JT, Peirson SN, et al. Short-wavelength light sensitivity of circadian, papillary, and visual awareness in humans lacking an outer retina. Curr BLIO. 2007;17:2122-2128. 28. Charman WN. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic PhysLIOog Opt. 2003;23(2):181-187. 29. Asplund R, Lindblad BE. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr. 2004; 38:69-75. 30. Jackson GR. Pilot study on the effect of a blue-blocking LIO on rod-mediated (scotopic) vision. ASCRS Symposium on Cataract, LIO and Refractive Surgery; 2005 Apr 1315; Washington, DC. 31. Hirvel H, Luukinen H, Lr E, et al. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology. 1996;103:871-7. 32. Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Lies lAge (POLA) study. Arch Ophthalmol. 2001;119:1463-8. 33. McCarty CA, Mukesh BN, Fu CL, et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol. 2001;119:1455-62. 34. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 1992;110:1701-8. 35. Khan JC, Thurlby DA, Shahid H, et al. Age-related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol. 2006;90(1):29-32. 36. Taylor HR, West S, Munoz B, Rosenthal FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye [840]. Arch Ophthalmol. 1992;110:99-104. 37. Cruickshanks KJ, Klein R, Klein BE, et al. Sunlight and the 5-year incidence of early age-related maculopathy [4900]. Arch Ophthalmol. 2001;119:246-50. 38. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study [409]. Ophthalmology. 1997;104:770-6. 39. Kato K, Nishida M, Yamane H, et al. Glistening formation in an AcrySof lens initiated by spinodal decomposition of the polymer network by temperature change. J Cataract Refract Surg. 2001;27:1493-8. 40. Moreno-Montanes J, Alvarez A, Rodriguez-Conde R, Fernandez-Hortelano A. Clinical factors related to the frequency and intensity of glistenings in AcrySof intraocular lenses. J Cataract Refract Surg. 2003;29:1980-4. 41. van der Mooren M, Bandhauer M, Piers P, Coppens J, van den Berg T. In vitro light scatter in acrylic intraocular lenses. Presented at: Netherlands Institute of Neuroscience; 2007 Sep 11; Amsterdam, The Netherlands. 42. Miyata A, Yaguchi S. Equilibrium water content and glistenings in acrylic intraocular lenses. J Cataract Refract Surg. 2004;30(8):1768-72. 43. Gregori NZ, Spencer TS, Mamalis N, Olson RJ. In vitro comparison of glistening formation among hydrophobic acrylic intraocular lenses. J Cataract Refract Surg. 2002;28(7):1262-8. 44. Davison JA. Clinical performance of Alcon SA30AL and SA60AT single-piece acrylic intraocular lenses. J Cataract Refract Surg. 2002;28:1112-23. 45. Dhaliwal DK, Mamalis N, Olson RJ, et al. Visual significance of glistenings seen in the AcrySof intraocular lens. J Cataract Refract Surg. 1996;22(4):452-7. 46. Omar O, Pirayesh A, Mamalis N, Olson RJ. In vitro analysis of AcrySof intraocular lens glistenings in AcryPak and Wagon Wheel packaging. J Cataract Refract Surg. 1998;24:107-13. 47. Oshika T, Shiokawa Y, Amano S, Mitomo K. Influence of glistenings on the optical quality of acrylic foldable intraocular lens. Br J Ophthalmol. 2001;85:1034-7. 48. Colin J, Orignac I. Glistening assessment in a large series of patients implanted with hydrophobic acrylic LIOs. Presented at The XXVI Congress of the European Society of Cataract and Refractive Surgeons; 2008 Sep 1317; Berlin, Germany. 49. Kugelberg M, Wejde G, Jayaram H, Zetterstrm C. Two-year follow-up of posterior capsule opacification after implantation of a hydrophilic or hydrophobic acrylic intraocular lens. Acta Ophthalmol. 2008;86(5):533-6. Epub 2007 Dec 11. 50. Kugelberg M, Wejde G, Jayaram H, Zetterstrm C. Posterior capsule opacification after implantation of a hydrophilic or a hydrophobic acrylic intraocular lens: one-year follow-up. J Cataract Refract Surg. 2006;32(10):1627-31.
Qualidade de Viso
TECNIS, ProTEC, e Tri-Fix so marcas da Abbott Laboratories. AcrySof e AcryPak so marcas da Alcon, Inc. SofPort marca da Bausch and Lomb, Inc.
www.liotecnis.com.br www.vistatek.com.br